American Association for the Study of Liver Diseases (AASLD)

Human liver
#American Association for the Study of Liver Diseases (AASLD) #DNA #Epigenomics #HBV #Liver disease #Tune Therapeutics #Viral hepatitis

Preclinical data suggests functional cure for HBV

Epigenome editing company Tune Therapeutics has showcased new data at the American Association for the Study of Liver Diseases (AASLD) conference, in support of its drive to develop a lasting, functional cure for chronic Hepatitis B Virus (HBV). Tune presented its lead HBV programme at the 2023 iteration of the… Read More

#News